概念板块个股详情
基因编辑 添加自选

基因编辑是一种新兴的比较精确的能对生物体基因组特定目标基因进行修饰的一种基因工程技术或过程,在基因研究、基因治疗和遗传改良等方面展示出了巨大的潜力。 该概念板块包含了业务涉及基因编辑的主要美股上市公司。

  • 1495.979
  • -15.485-1.02%
收盘价 11/06 16:00 (美东)
1532.716最高价1479.648最低价
成分股: 10只领涨股: SGMO+14.35%
分时
  • 5日
  • 日K
  • 周K
  • 月K
  • 季K
  • 年K
成分股
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
自选
SGMOSangamo Therapeutics
2.4700.310+14.35%1203.98万2764.66万2.1602.1602.5551.9605.14亿4.68亿2.08亿1.90亿+24.12%+60.39%+212.66%+153.31%+305.78%+550.00%+354.63%--6.35%亏损亏损27.55%生物技术
BEAMBeam Therapeutics
26.6202.690+11.24%202.09万5320.06万26.00023.93027.30025.24022.04亿18.17亿8280.56万6826.93万+18.31%+22.00%+13.57%+9.37%+11.90%+16.24%-2.20%--2.96%亏损亏损8.61%生物技术
CRBUCaribou Biosciences
2.7500.190+7.42%289.60万780.19万2.6902.5602.7802.5352.49亿2.24亿9055.27万8138.88万+39.59%+43.23%+48.65%+47.85%-23.40%-39.29%-52.01%--3.56%亏损亏损9.57%生物技术
EDITEditas Medicine
3.2800.160+5.13%422.59万1383.63万3.3303.1203.4003.0602.71亿2.50亿8254.81万7622.41万+8.61%+2.18%+5.13%-17.79%-44.31%-60.95%-67.62%--5.54%亏损亏损10.89%生物技术
NTLAIntellia Therapeutics
16.0600.630+4.08%344.86万5515.31万15.81015.43016.23015.52016.31亿16.11亿1.02亿1.00亿+12.07%-19.46%-9.01%-28.34%-38.63%-43.55%-47.33%--3.44%亏损亏损4.60%生物技术
APLSApellis Pharmaceuticals
28.8300.755+2.69%384.29万1.10亿29.93028.07529.99027.27035.86亿24.40亿1.24亿8463.92万+4.04%+6.86%+7.17%-19.29%-31.36%-38.65%-51.84%--4.54%亏损亏损9.69%生物技术
CRSPCRISPR Therapeutics
50.7200.360+0.71%227.74万1.15亿51.80050.36051.88049.39043.29亿42.46亿8535.35万8371.83万+5.82%+10.26%+11.72%+5.18%-8.89%-7.31%-18.98%--2.72%亏损亏损4.94%生物技术
VRTX福泰制药
493.640-6.240-1.25%164.87万8.12亿505.350499.880506.650485.2901271.27亿1267.45亿2.58亿2.57亿+3.91%+5.02%+5.49%+5.57%+12.03%+30.95%+21.32%--0.64%亏损35.544.27%生物技术
A安捷伦科技
137.780-2.630-1.87%252.89万3.50亿143.000140.410143.070137.040395.88亿394.39亿2.87亿2.86亿+4.78%+3.57%-4.85%+0.42%-10.40%+26.81%-0.39%0.68%0.88%28.6432.884.30%诊断与研究
BLUEbluebird bio
0.439-0.013-2.87%657.06万292.20万0.4460.4520.4610.4328520.56万8481.23万1.94亿1.93亿-10.11%-14.30%-11.14%-58.55%-58.15%-86.52%-68.16%--3.40%亏损亏损6.43%生物技术